Moderna Inc
General ticker "MRNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.2B
Moderna Inc does not follow the US Stock Market performance with the rate: -18.5%.
Estimated limits based on current volatility of 3.1%: low 38.52$, high 41.02$
Factors to consider:
- Company included in S&P500 list
- Current price 24.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [52.43$, 110.65$]
- 2024-12-30 to 2025-12-30 estimated range: [42.66$, 91.47$]
Financial Metrics affecting the MRNA estimates:
- Negative: Non-GAAP EPS, $ of -4.27 <= 0.10
- Negative: Operating profit margin, % of -38.23 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -8.94 <= 2.35
- Positive: Inventory ratio change, % of 0.28 <= 1.08
Short-term MRNA quotes
Long-term MRNA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $18,471.00MM | $19,263.00MM | $6,848.00MM |
| Operating Expenses | $5,175.00MM | $9,843.00MM | $11,087.00MM |
| Operating Income | $13,296.00MM | $9,420.00MM | $-4,239.00MM |
| Non-Operating Income | $-11.00MM | $155.00MM | $297.00MM |
| Interest Expense | $18.00MM | $29.00MM | $38.00MM |
| R&D Expense | $1,991.00MM | $3,295.00MM | $4,845.00MM |
| Income(Loss) | $13,285.00MM | $9,575.00MM | $-3,942.00MM |
| Taxes | $1,083.00MM | $1,213.00MM | $772.00MM |
| Profit(Loss) | $12,202.00MM | $8,362.00MM | $-4,714.00MM |
| Stockholders Equity | $14,145.00MM | $19,123.00MM | $13,854.00MM |
| Inventory | $1,441.00MM | $949.00MM | $202.00MM |
| Assets | $24,669.00MM | $25,858.00MM | $18,426.00MM |
| Operating Cash Flow | $13,620.00MM | $4,981.00MM | $-3,118.00MM |
| Capital expenditure | $284.00MM | $400.00MM | $707.00MM |
| Investing Cash Flow | $-8,523.00MM | $-5,176.00MM | $4,206.00MM |
| Financing Cash Flow | $-873.00MM | $-3,448.00MM | $-1,377.00MM |
| Earnings Per Share* | $30.28 | $21.22 | $-12.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.